Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SHOC2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | ZBED3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | ERMAP | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | CDKN1C | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | B3GNTL1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | RASSF7 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | OR52A5 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | ZFP36 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | CHKA | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | RSC1A1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |